PharmAla Biotech Holdings Inc. announced that data from its computational Drug Discovery program, in conjunction with the University of Waterloo (laboratory of Dr. James Gauld) and made possible by funding from MITACS, will be published in the scientific journal ACS Chemical Neuroscience this week. The article Exploring Structure- Activity Relationships in Phenethylamines: A Path to Novel Mental Health Therapies investigates the essential aspects of how the structure of phenethylamine molecules relates to their activity. It focuses on identifying key targets that are crucial for optimizing the safety and effectiveness of these compounds.

The publication follows the February 1 publication of the PCT patent application publication for PharmAla's P1 molecule; PharmAla's P1 patent application has been accepted for the Patent Pro prosecution Highway by the USPTO.